Literature DB >> 24943193

Genetic variations in RORα are associated with chronic obstructive pulmonary disease.

Yiming Yuan1, Xiaoming Hou2, Jinlong Zhang2, Yulong Chen2, Yulin Feng3, Zhiguang Su2.   

Abstract

Retinoic acid receptor-related orphan receptor-α (RORα) plays a key role in the regulation of lipid and cholesterol metabolism that has been implicated in the development of chronic obstructive pulmonary disease (COPD). The aim of this study was to determine the frequencies of single-nucleotide polymorphisms (SNPs) in RORα gene in a Chinese population and their possible association with COPD susceptibility. Nine tagging SNPs, including rs17270181, rs1898413, rs17270216, rs8033552, rs8036966, rs7169364, rs340002, rs340023 and rs11630262, were screened in 279 COPD patients and 367 controls by the SNaPshot method. Association analysis of genotypes and haplotypes constructed from these loci with COPD was conducted under different genetic models. Alleles or genotypes of rs8033552 distributed significantly differently in COPD patients and controls (allele: P=0.0001, false discovery rate (FDR) Q=0.004, odds ratios (OR): 1.62 and 95% confidence interval (CI): 1.27-2.07; genotype: P=0.0005, FDR Q=0.008). The allele A at rs8033552 was potentially associated with an increased risk of COPD in additive model, displaying ORs of 1.62 (95% CI: 1.17-2.26, P=0.004, FDR Q=0.019) in subjects with genotypes AG vs GG and 2.69 (95% CI: 1.47-4.93, P=0.001, FDR Q=0.011) in subjects with genotypes AA vs GG, respectively. In haplotype analysis, we observed haplotypes GGAGATGTG and GGAGCTGTG had protective effects, whereas haplotypes GGAGATACA and GGAGATACG were significantly associated with the increased risk of COPD. These data suggest that RORα may be a potential risk gene for COPD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24943193     DOI: 10.1038/jhg.2014.48

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  43 in total

1.  Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation.

Authors:  Maisa Jaradat; Cliona Stapleton; Stephen L Tilley; Darlene Dixon; Christopher J Erikson; Joshua G McCaskill; Hong Soon Kang; Martin Angers; Grace Liao; Jennifer Collins; Sherry Grissom; Anton M Jetten
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

2.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

3.  Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema.

Authors:  Ying Shi; Jiaofei Cao; Jane Gao; Liang Zheng; Andrew Goodwin; Chang Hyoek An; Avignat Patel; Janet S Lee; Steven R Duncan; Naftali Kaminski; Kusum V Pandit; Ivan O Rosas; Augustine M K Choi; Danielle Morse
Journal:  Am J Respir Crit Care Med       Date:  2012-06-28       Impact factor: 21.405

4.  Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.

Authors:  Annelise Genoux; Hélène Dehondt; Audrey Helleboid-Chapman; Christian Duhem; Dean W Hum; Geneviève Martin; Len A Pennacchio; Bart Staels; Jamila Fruchart-Najib; Jean-Charles Fruchart
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-24       Impact factor: 8.311

5.  The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.

Authors:  P Delerive; D Monté; G Dubois; F Trottein; J Fruchart-Najib; J Mariani; J C Fruchart; B Staels
Journal:  EMBO Rep       Date:  2001-01       Impact factor: 8.807

6.  Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha.

Authors:  A Mamontova; S Séguret-Macé; B Esposito; C Chaniale; M Bouly; N Delhaye-Bouchaud; G Luc; B Staels; N Duverger; J Mariani; A Tedgui
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

7.  The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity.

Authors:  Patrick Lau; Rebecca L Fitzsimmons; Suryaprakash Raichur; Shu-Ching M Wang; Adriane Lechtken; George E O Muscat
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

8.  Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease.

Authors:  Si-cheng Xu; Jiang-ying Kuang; Jin Liu; Chun-lan Ma; Yu-lin Feng; Zhi-guang Su
Journal:  Acta Pharmacol Sin       Date:  2012-07-16       Impact factor: 6.150

Review 9.  New anti-inflammatory targets for chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

10.  Genetic variations in ADIPOQ gene are associated with chronic obstructive pulmonary disease.

Authors:  Yiming Yuan; Haiou Jiang; Jiangying Kuang; Xiaoming Hou; Yulin Feng; Zhiguang Su
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more
  3 in total

Review 1.  Immune-related gene polymorphisms in pulmonary diseases.

Authors:  Dhirendra P Singh; Prathyusha Bagam; Malaya K Sahoo; Sanjay Batra
Journal:  Toxicology       Date:  2017-03-30       Impact factor: 4.221

2.  Genetic variants of CDH13 determine the susceptibility to chronic obstructive pulmonary disease in a Chinese population.

Authors:  Yi-ming Yuan; Jin-long Zhang; Si-cheng Xu; Ren-song Ye; Dan Xu; You Zhang; Yan-Jie Zhang; Yu-long Chen; Yu-lan Liu; Zhi-guang Su
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

Review 3.  Impact of air quality guidelines on COPD sufferers.

Authors:  Youcheng Liu; Shuang Yan; Karen Poh; Suyang Liu; Emanehi Iyioriobhe; David A Sterling
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.